A detailed history of Bennicas & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Bennicas & Associates, Inc. holds 23,995 shares of SNY stock, worth $1.14 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
23,995
Previous 23,995 -0.0%
Holding current value
$1.14 Million
Previous $1.16 Million -0.0%
% of portfolio
0.74%
Previous 0.67%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$37.22 - $100.5 $7,444 - $20,100
-200 Reduced 0.83%
23,995 $912,000
Q2 2022

Jul 12, 2022

BUY
$48.99 - $57.46 $3,429 - $4,022
70 Added 0.29%
24,195 $1.21 Million
Q1 2022

Apr 15, 2022

SELL
$48.48 - $53.65 $4,848 - $5,365
-100 Reduced 0.41%
24,125 $1.24 Million
Q4 2021

Jan 14, 2022

SELL
$47.07 - $52.35 $9,414 - $10,470
-200 Reduced 0.82%
24,225 $1.21 Million
Q1 2021

Apr 15, 2021

SELL
$45.46 - $50.51 $22,730 - $25,255
-500 Reduced 2.01%
24,425 $1.21 Million
Q3 2020

Oct 15, 2020

SELL
$49.47 - $53.77 $14,841 - $16,131
-300 Reduced 1.19%
24,925 $1.25 Million
Q1 2020

Apr 15, 2020

SELL
$38.02 - $51.66 $36,119 - $49,077
-950 Reduced 3.63%
25,225 $1.1 Million
Q4 2019

Jan 17, 2020

SELL
$44.25 - $50.86 $23,629 - $27,159
-534 Reduced 2.0%
26,175 $1.31 Million
Q2 2019

Jul 12, 2019

SELL
$40.43 - $44.3 $3,032 - $3,322
-75 Reduced 0.28%
26,709 $1.16 Million
Q1 2019

Apr 16, 2019

SELL
$40.83 - $45.43 $8,166 - $9,086
-200 Reduced 0.74%
26,784 $1.19 Million
Q4 2017

Jan 24, 2018

SELL
$42.86 - $50.61 $38,574 - $45,549
-900 Reduced 3.23%
26,984 $1.16 Million
Q3 2017

Oct 25, 2017

BUY
$47.04 - $50.34 $1.31 Million - $1.4 Million
27,884
27,884 $1.39 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Bennicas & Associates, Inc. Portfolio

Follow Bennicas & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennicas & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bennicas & Associates, Inc. with notifications on news.